The $66 billion acquisition of Monsanto by Bayer is set to consolidate the hold of MNCs over the organised seeds & agrochemicals industry in India, constituting around 60% of the total industry. This is the third major global merger in the agricultural space after Dow Chemical-DuPont and ChemChina-Syngenta. The Indian arms of Monsanto and Bayer – Monsanto India and Bayer Cropscience – have a market capitalisation of Rs.4,220 crore & Rs.14,800 crore respectively. Investors certainly are enthused about the acquisition. On 14th September, when news filtered in suggesting the deal was about to be finalised, Bayer Cropscience closed at Rs.4,115, 1.3% higher than the previous close, while Monsanto India closed at Rs.2,571, a significant 10.3% higher than the previous day’s close.
A Significant Handshake
Bayer’s acquisition of Monsanto is great for shareholders but negative for farmers
Summer wine and salad
Kishore Singh - January 19, 2015
The million-dollar question: Is investing a game of luck or skill?
Shankar Sharma - May 04, 2021
Every crisis is an opportunity, if you are on the right side of equities
Samir Arora - May 04, 2021
Viraj Mehta trusts the toughness and bounce of a company that has seen many trials
Viraj Mehta - May 04, 2021
Safir Anand spots a mid-sized company with the right chemistry and catalytic circumstances
Safir Anand - May 07, 2021